E-DRUG Archives (by thread)

Date Index

[e-drug] Drugs with narrow therapeutic index (cont'd), Perla Mordujovich

[e-drug] WHO Medicnes bookshelf (cont'd), Richard Laing

[e-drug] WHO EML Committee agenda 31.03 - 03.04 2003 (cont'd), Robin Gray

[e-drug] RUD course - French (cont'd), Kathy Holloway

[e-drug] Request to review excerpt PhD thesis, Donna van Bogaert

[e-drug] WHO, UNAIDS and UNICEF meet with generics industry, Hans Hogerzeil

[e-drug] Origins of AIDS (cont'd), George Schmid

<Possible follow-ups>
[e-drug] Origins of AIDS (cont'd), Beverley Snell
[e-drug] Origins of AIDS (cont'd), E-drug
[e-drug] Origins of AIDS (cont'd), Andy Gray
[e-drug] Origins of AIDS (cont'd), David Gisselquist
[e-drug] Origins of AIDS (cont'd), E-drug

[e-drug] Blockbuster drugs, E-drug

[e-drug] Drug trials, E-drug

[e-drug] WHO Indicators (cont'd), Kathy Holloway

[e-drug] World's first-ever anti-smoking treaty, e-drug

[e-drug] Literature on PTC efficiency, S. Lerkiatbundit

[e-drug] US Abortion Politics and Global Fund, Leela McCullough

[e-drug] Chinese-developed malarial drug Artekin, Leela McCullough

[e-drug] Generic Prescribing to enhance access to medicines, Azhar Hussain

[e-drug] Pharmaceutical inventory control software, mSupply

[e-drug] Drug utilization review write up, Wong Wai See

[e-drug] WHO and training (cont'd), Kae Ting Trouilloud

[e-drug] Correct use of antiretrovirals, E-drug

[e-drug] Generic ARV production and sales, James Love

[e-drug] Table of contents for PhRMA 301 submission, James Love

[e-drug] Please help ban drug ads to the public, Peter Mansfield

[e-drug] How a statin might destroy a drug company, e-drug

[e-drug] South Africa stalls again on access to HIV drugs, e-drug

[e-drug] FTC case against BMS for blocking generic entry, James Love

[e-drug] Shortages of medicines, Stein Lyftingsmo

[e-drug] Re: Origins of AIDS (cont'd), Kirsten Myhr

[e-drug] Workshop on pharmacogenetics of drug metabolism, Collen Masimirembwa

[e-drug] Drug prices in Sri Lanka, Valeria Frighi

[e-drug] Water purifying in developing countries, E-drug

[e-drug] The most cost effective way to improve health this year?, Peter Mansfield

[e-drug] Saline Solution (0.9%) versus Ringer's lactate, Sergio Palacio

[e-drug] Drug utilization review write up (cont'd), Jonathan Dartnell

[e-drug] Saline Solution (0.9%) versus Ringer's lactate (cont'd), Joel Lexchin

<Possible follow-ups>
[e-drug] Saline Solution (0.9%) versus Ringer's lactate (cont'd), M. Haniki Nik M

[e-drug] Correct use of antiretrovirals (cont'd), Andy Gray

<Possible follow-ups>
[e-drug] Correct use of antiretrovirals (cont'd), Mary Ojoo
[e-drug] Correct use of antiretrovirals (cont'd), Daniel Seyoum

[e-drug] Free Educational Malaria CD-ROMs, Graham . Icke

[e-drug] New HIV & AIDS e-mail newsletter, Julian Meldrum

[e-drug] Thank you for supporting a ban on DTCA in NZ, Peter R Mansfield

[e-drug] Origin of AIDS (cont'd), Beverley Snell

<Possible follow-ups>
[e-drug] Origin of AIDS (cont'd), e-drug

[e-drug] Dipyrone and agranulocytosis, E-drug

[e-drug] WHO and training (con't): Search engine tips, Libby Levison

[e-drug] Dipyrone and agranulocytosis (cont'd), Gaut Gadeholt

<Possible follow-ups>
[e-drug] Dipyrone and agranulocytosis (cont'd), Pablo Adolfo Elías

[e-drug] WHO Expert Committee on selection of essential medicines, Richard Laing

[e-drug] 5th, updated WHO prequalification list, WilbertBannenberg

[e-drug] Prescription for pain (Le Monde Diplomatique, March 2003), Richard Laing

[e-drug] Quality use of medicines indicators, Libby Roughead

[e-drug] New Consensus Statement on hypertension treatment, E-drug

[e-drug] Geneva meeting on global R&D framework, 29 April 2003, James Love

[e-drug] Deceptive practices of drug company, E-drug

[e-drug] Tablet-splitting with FDCs (esp. antiretrovirals), Julian Meldrum

[e-drug] Statin prescribing information sought, Peter Lurie

[e-drug] Patent law, E-drug

[e-drug] Aids protests in South Africa, Valeria Frighi

[e-drug] Tablet-splitting with FDCs, esp. antiretrovirals (cont'd), Tim Read

<Possible follow-ups>
[e-drug] Tablet-splitting with FDCs, esp. antiretrovirals (cont'd), Carolyn Green

[e-drug] World TB Day 2003, Rachel Cohen

[e-drug] Guidelines for labelling and packaging of medicines, Stein Lyftingsmo

[e-drug] Investors pressure drug firms on pricing, Ellen 't Hoen

[e-drug] Investors pressure drug firms on pricing (cont'd), Patrice Trouiller

[e-drug] WHO article on comparative pharmaceutical expenditures, Sunaina Sharma

[e-drug] Concept of generic drugs, Carmen Prez Casas

[e-drug] WHO article on pharmaceutical expenditures (cont'd), Joel Lexchin

<Possible follow-ups>
[e-drug] WHO article on pharmaceutical expenditures (cont'd), Andrew Creese

[e-drug] Training workshop on writing about medicines for people, Stein Lyftingsmo

[e-drug] Drug Bulletin Special Issue on World TB Day, Azhar Hussain

[e-drug] Concept of generic drugs (cont'd), Srinivas Tata

<Possible follow-ups>
[e-drug] Concept of generic drugs (cont'd), Reinhard Huss
[e-drug] Concept of generic drugs (cont'd), Claudia Vacca

[e-drug] Patent law (cont'd), Srinivas Tata

<Possible follow-ups>
[e-drug] Patent law (cont'd), Murtada Sesay

[e-drug] Drugs from developing countries, Srinivas Tata

[e-drug] Drugs from developing countries (cont'd), Jerome.Dumoulin

[e-drug] Concerns about weakening proposals for cheap drugs, E-drug

[e-drug] USA pressure on Australia's affordable drugs scheme, E-drug

[e-drug] Reply from Dr Attaran to Dr Srinivas, Srinivas Tata

[e-drug] Reply from Dr Attaran to Dr Srinivas (cont'd), Mohga Kamal Smith

<Possible follow-ups>
[e-drug] Reply from Dr Attaran to Dr Srinivas (cont'd), Aniruddha Malpani
[e-drug] Reply from Dr Attaran to Dr Srinivas (cont'd), Praveen Bhasa
[e-drug] Reply from Dr Attaran to Dr Srinivas (cont'd), Malcolm Bryant
[e-drug] Reply from Dr Attaran to Dr Srinivas (cont'd), Ram Dixit
[e-drug] Reply from Dr Attaran to Dr Srinivas (cont'd), Sarah Sellers
[e-drug] Reply from Dr Attaran to Dr Srinivas (cont'd), Srinivas Tata

[e-drug] Pharmaceutical companies and the third world, E-drug

[e-drug] FDA public health advisory on Lindane products, E-drug

[e-drug] Ethical standards in clinical trials of Antiretroviral drugs, Jude Ike Nwokike

[e-drug] Expiry dates of drugs, Karin

[e-drug] Research for DOT-HAART paper, Pranish Kantesaria

[e-drug] WHO Essential Drugs Committee meets this week, WilbertBannenberg

Mail converted by MHonArc 2.6.8